Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to 1.09%.

  • Biomerica's Return on Capital Employed fell 500.0% to 1.09% in Q4 2025 from the same period last year, while for Nov 2025 it was 1.09%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.88% for FY2025, which is 2200.0% down from last year.
  • As of Q4 2025, Biomerica's Return on Capital Employed stood at 1.09%, which was down 500.0% from 1.04% recorded in Q3 2025.
  • Biomerica's Return on Capital Employed's 5-year high stood at 0.36% during Q2 2022, with a 5-year trough of 1.09% in Q4 2025.
  • In the last 5 years, Biomerica's Return on Capital Employed had a median value of 0.75% in 2023 and averaged 0.76%.
  • In the last 5 years, Biomerica's Return on Capital Employed soared by 3000bps in 2022 and then crashed by -4900bps in 2024.
  • Quarter analysis of 5 years shows Biomerica's Return on Capital Employed stood at 0.78% in 2021, then rose by 17bps to 0.64% in 2022, then grew by 8bps to 0.59% in 2023, then crashed by -75bps to 1.03% in 2024, then decreased by -5bps to 1.09% in 2025.
  • Its last three reported values are 1.09% in Q4 2025, 1.04% for Q3 2025, and 1.04% during Q2 2025.